BYRNA TECHNOLOGIES INC (BYRN)

US12448X2018 - Common Stock

29.56  +1.11 (+3.9%)

After market: 28.157 -1.4 (-4.75%)

Fundamental Rating

5

BYRN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. BYRN has a great financial health rating, but its profitability evaluates not so good. BYRN shows excellent growth, but is valued quite expensive already.



3

1. Profitability

1.1 Basic Checks

BYRN had positive earnings in the past year.
BYRN had a positive operating cash flow in the past year.
BYRN had negative earnings in each of the past 5 years.
In multiple years BYRN reported negative operating cash flow during the last 5 years.

1.2 Ratios

BYRN's Return On Assets of 3.88% is in line compared to the rest of the industry. BYRN outperforms 55.38% of its industry peers.
Looking at the Return On Equity, with a value of 5.14%, BYRN is in line with its industry, outperforming 50.77% of the companies in the same industry.
With a Return On Invested Capital value of 2.90%, BYRN perfoms like the industry average, outperforming 43.08% of the companies in the same industry.
Industry RankSector Rank
ROA 3.88%
ROE 5.14%
ROIC 2.9%
ROA(3y)-11.75%
ROA(5y)-43.58%
ROE(3y)-14.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BYRN has a Profit Margin of 3.12%. This is comparable to the rest of the industry: BYRN outperforms 47.69% of its industry peers.
The Operating Margin of BYRN (2.33%) is comparable to the rest of the industry.
BYRN's Gross Margin of 60.28% is amongst the best of the industry. BYRN outperforms 95.38% of its industry peers.
BYRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.33%
PM (TTM) 3.12%
GM 60.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.95%
GM growth 5Y18.23%

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BYRN is destroying value.
The number of shares outstanding for BYRN has been increased compared to 1 year ago.
Compared to 5 years ago, BYRN has more shares outstanding
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BYRN has an Altman-Z score of 28.31. This indicates that BYRN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 28.31, BYRN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 28.31
ROIC/WACC0.3
WACC9.68%

2.3 Liquidity

A Current Ratio of 3.51 indicates that BYRN has no problem at all paying its short term obligations.
The Current ratio of BYRN (3.51) is better than 81.54% of its industry peers.
A Quick Ratio of 1.93 indicates that BYRN should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.93, BYRN is doing good in the industry, outperforming 73.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 1.93

8

3. Growth

3.1 Past

BYRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 600.00%, which is quite impressive.
BYRN shows a strong growth in Revenue. In the last year, the Revenue has grown by 70.62%.
Measured over the past years, BYRN shows a very strong growth in Revenue. The Revenue has been growing by 179.50% on average per year.
EPS 1Y (TTM)600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)70.62%
Revenue growth 3Y37.04%
Revenue growth 5Y179.5%
Sales Q2Q%194.34%

3.2 Future

Based on estimates for the next years, BYRN will show a very strong growth in Earnings Per Share. The EPS will grow by 71.15% on average per year.
BYRN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 36.97% yearly.
EPS Next Y257.64%
EPS Next 2Y150.49%
EPS Next 3Y71.15%
EPS Next 5YN/A
Revenue Next Year113.98%
Revenue Next 2Y66.29%
Revenue Next 3Y49.91%
Revenue Next 5Y36.97%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

BYRN is valuated quite expensively with a Price/Earnings ratio of 147.80.
Compared to the rest of the industry, the Price/Earnings ratio of BYRN is on the same level as its industry peers.
When comparing the Price/Earnings ratio of BYRN to the average of the S&P500 Index (27.73), we can say BYRN is valued expensively.
The Price/Forward Earnings ratio is 62.86, which means the current valuation is very expensive for BYRN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BYRN is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of BYRN to the average of the S&P500 Index (22.83), we can say BYRN is valued expensively.
Industry RankSector Rank
PE 147.8
Fwd PE 62.86

4.2 Price Multiples

61.54% of the companies in the same industry are cheaper than BYRN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BYRN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 66.9
EV/EBITDA 206.42

4.3 Compensation for Growth

BYRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BYRN's earnings are expected to grow with 71.15% in the coming years.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y150.49%
EPS Next 3Y71.15%

0

5. Dividend

5.1 Amount

No dividends for BYRN!.
Industry RankSector Rank
Dividend Yield N/A

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (12/20/2024, 8:00:01 PM)

After market: 28.157 -1.4 (-4.75%)

29.56

+1.11 (+3.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-09 2024-10-09/bmo
Earnings (Next)02-12 2025-02-12/amc
Inst Owners40.13%
Inst Owner Change5.53%
Ins Owners19.4%
Ins Owner Change-0.72%
Market Cap672.79M
Analysts81.82
Price Target23.14 (-21.72%)
Short Float %15.81%
Short Ratio4.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)140.02%
Min EPS beat(2)47.04%
Max EPS beat(2)233%
EPS beat(4)3
Avg EPS beat(4)68.48%
Min EPS beat(4)-198.04%
Max EPS beat(4)233%
EPS beat(8)5
Avg EPS beat(8)-42.67%
EPS beat(12)6
Avg EPS beat(12)-43.53%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.75%
Min Revenue beat(2)-1.7%
Max Revenue beat(2)5.2%
Revenue beat(4)3
Avg Revenue beat(4)15.85%
Min Revenue beat(4)-1.7%
Max Revenue beat(4)42.11%
Revenue beat(8)3
Avg Revenue beat(8)-0.17%
Revenue beat(12)4
Avg Revenue beat(12)-1.99%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)25.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-52.77%
EPS NY rev (1m)0%
EPS NY rev (3m)50%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.01%
Revenue NY rev (1m)3.32%
Revenue NY rev (3m)11.11%
Valuation
Industry RankSector Rank
PE 147.8
Fwd PE 62.86
P/S 9.16
P/FCF 66.9
P/OCF 56.06
P/B 15.11
P/tB 17.3
EV/EBITDA 206.42
EPS(TTM)0.2
EY0.68%
EPS(NY)0.47
Fwd EY1.59%
FCF(TTM)0.44
FCFY1.49%
OCF(TTM)0.53
OCFY1.78%
SpS3.23
BVpS1.96
TBVpS1.71
PEG (NY)0.57
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.88%
ROE 5.14%
ROCE 3.67%
ROIC 2.9%
ROICexc 5.11%
ROICexgc 6.51%
OM 2.33%
PM (TTM) 3.12%
GM 60.28%
FCFM 13.7%
ROA(3y)-11.75%
ROA(5y)-43.58%
ROE(3y)-14.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.95%
GM growth 5Y18.23%
F-Score8
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 133.68%
Cap/Sales 2.65%
Interest Coverage 250
Cash Conversion 379.54%
Profit Quality 439.13%
Current Ratio 3.51
Quick Ratio 1.93
Altman-Z 28.31
F-Score8
WACC9.68%
ROIC/WACC0.3
Cap/Depr(3y)265.47%
Cap/Depr(5y)361.78%
Cap/Sales(3y)4.31%
Cap/Sales(5y)9.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next Y257.64%
EPS Next 2Y150.49%
EPS Next 3Y71.15%
EPS Next 5YN/A
Revenue 1Y (TTM)70.62%
Revenue growth 3Y37.04%
Revenue growth 5Y179.5%
Sales Q2Q%194.34%
Revenue Next Year113.98%
Revenue Next 2Y66.29%
Revenue Next 3Y49.91%
Revenue Next 5Y36.97%
EBIT growth 1Y124.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year207.22%
EBIT Next 3Y62.38%
EBIT Next 5Y47.42%
FCF growth 1Y159.01%
FCF growth 3Y39.12%
FCF growth 5YN/A
OCF growth 1Y186.09%
OCF growth 3Y15.29%
OCF growth 5YN/A